NCT03886753View on ClinicalTrials.gov

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

TerminatedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
ALSAutism Spectrum DisorderCancerSpasticity, MuscleDyskinetic SyndromeEpilepsyGlaucomaHuntington DiseaseInflammatory Bowel Disease (IBD)Multiple SclerosisNeuropathyOpioid UseParkinson DiseaseHIV/AIDSPtsdIntractable PainSickle Cell DiseaseTerminal Illness
Interventions
OTHER

Registry

Collect data on subjects

OTHER

PK microsampling of blood

Obtain 5 microsamples of blood from subjects via a fingerstick.

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

Sponsors

Collaborators (1)

Ilera Healthcare
All Listed Sponsors
collaborator

Ilera Healthcare

UNKNOWN

lead

Children's Hospital of Philadelphia

OTHER

NCT03886753 - Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products | Biotech Hunter | Biotech Hunter